Analysts Set STERIS plc (NYSE:STE) Target Price at $258.75

Shares of STERIS plc (NYSE:STEGet Free Report) have been assigned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $258.75.

A number of analysts have recently weighed in on the stock. JMP Securities restated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. Stephens reissued an “overweight” rating and set a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler upped their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd.

Check Out Our Latest Stock Analysis on STERIS

STERIS Stock Down 3.7 %

STE stock opened at $213.16 on Thursday. The stock’s 50 day simple moving average is $223.23 and its 200 day simple moving average is $220.57. The company has a market cap of $20.94 billion, a P/E ratio of 45.26 and a beta of 0.87. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS has a fifty-two week low of $197.82 and a fifty-two week high of $248.24.

STERIS (NYSE:STEGet Free Report) last released its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, research analysts expect that STERIS will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were paid a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.07%. The ex-dividend date was Thursday, February 20th. STERIS’s payout ratio is currently 48.41%.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of STE. Principal Financial Group Inc. boosted its holdings in STERIS by 9.5% during the 3rd quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider’s stock valued at $270,230,000 after acquiring an additional 96,336 shares during the period. Public Sector Pension Investment Board boosted its stake in shares of STERIS by 13.2% during the third quarter. Public Sector Pension Investment Board now owns 4,283 shares of the medical equipment provider’s stock valued at $1,039,000 after purchasing an additional 500 shares during the period. Atom Investors LP grew its holdings in shares of STERIS by 37.8% in the third quarter. Atom Investors LP now owns 3,716 shares of the medical equipment provider’s stock worth $901,000 after purchasing an additional 1,020 shares during the last quarter. Hilltop Holdings Inc. purchased a new position in STERIS in the 3rd quarter worth about $218,000. Finally, Investment Management Corp of Ontario lifted its holdings in STERIS by 55.4% during the 3rd quarter. Investment Management Corp of Ontario now owns 3,365 shares of the medical equipment provider’s stock valued at $816,000 after buying an additional 1,200 shares in the last quarter. Institutional investors own 94.69% of the company’s stock.

STERIS Company Profile

(Get Free Report

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Featured Stories

Analyst Recommendations for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.